Gene · 7337
Papers4,306
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,306
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A. | Neurotherapeutics | 2022 | 35534672 | PubTator, text mining | PubMed |
| UBE3A deletion enhances the efficiency of immunotherapy in non-small-cell lung cancer. | Bioengineered | 2022 | 35531878 | PubTator, text mining | PubMed |
| Comprehensive Target Screening and Cellular Profiling of the Cancer-Active Compound b-AP15 Indicate Abrogation of Protein Homeostasis and Organelle Dysfunction as the Primary Mechanism of Action. | Front Oncol | 2022 | 35530310 | PubTator, text mining | PubMed |
| Disorders of ubiquitylation: unchained inflammation. | Nat Rev Rheumatol | 2022 | 35523963 | PubTator, text mining | PubMed |
| The macrophage-associated microRNA-4715-3p / Gasdermin D axis potentially indicates fibrosis progression in nonalcoholic fatty liver disease: evidence from transcriptome and biological data. | Bioengineered | 2022 | 35521691 | PubTator, text mining | PubMed |
| LncRNA MBNL1-AS1 Represses Proliferation and Cancer Stem-Like Properties of Breast Cancer through MBNL1-AS1/ZFP36/CENPA Axis. | J Oncol | 2022 | 35518784 | PubTator, text mining | PubMed |
| A Potential Mechanism for Targeting Aggregates With Proteasomes and Disaggregases in Liquid Droplets. | Front Aging Neurosci | 2022 | 35517053 | PubTator, text mining | PubMed |
| Decoding the Therapeutic Implications of the ERα Stability and Subcellular Distribution in Breast Cancer. | Front Endocrinol (Lausanne) | 2022 | 35498431 | PubTator, text mining | PubMed |
| What Makes Organoids Good Models of Human Neurogenesis? | Front Neurosci | 2022 | 35495031 | PubTator, text mining | PubMed |
| Generation of an induced pluripotent stem cell line from a patient with Angelman syndrome carrying UBE3A mutation. | Stem Cell Res | 2022 | 35489268 | PubTator, text mining | PubMed |
| Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases. | RNA Biol | 2022 | 35482908 | PubTator, text mining | PubMed |
| The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses. | Elife | 2022 | 35475759 | PubTator, text mining | PubMed |
High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression. | J Virol | 2022 | 35475668 | PubTator, text mining | PubMed |
| Value of genetic testing for pediatric epilepsy: Driving earlier diagnosis of ceroid lipofuscinosis type 2 Batten disease. | Epilepsia | 2022 | 35474188 | PubTator, text mining | PubMed |
| Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants. | Genome Med | 2022 | 35468861 | PubTator, text mining | PubMed |
| Role of Apoptosis in HIV Pathogenesis. | Adv Virol | 2022 | 35462964 | PubTator, text mining | PubMed |
| Exploration on the Mechanism of Ubiquitin Proteasome System in Cerebral Stroke. | Front Aging Neurosci | 2022 | 35462700 | PubTator, text mining | PubMed |
| Genetic variability of E6 and E7 genes of human papillomavirus type 58 in Jingzhou, Hubei Province of central China. | Virol J | 2022 | 35459244 | PubTator, text mining | PubMed |
| TP53 Gene Therapy as a Potential Treatment for Patients with COVID-19. | Viruses | 2022 | 35458469 | PubTator, text mining | PubMed |
| Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism. | Genes (Basel) | 2022 | 35456477 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7337/papers?page=41